Concepedia

Gemcitabine versus gemcitabine plus dalteparin thromboprophylaxis in pancreatic cancer

Anthony Maraveyas, Justin S. Waters, Rajarshi Roy, D. Fyfe, David Propper, F. Lofts, Joseph Sgouros, Eric Gardiner, K R Wedgwood, Camille Ettelaie,

European Journal of Cancer · 2011 · 316 citations · 17 references

DOIFull text

Open access

Concepts

References

17

New Guidelines to Evaluate the Response to Treatment in Solid Tumors

Patrick Therasse, Susan G. Arbuck, Elizabeth A. Eisenhauer et al. · JNCI Journal of the National Cancer Institute · 2000 · 15.7K citations

, , +12

Cancer Statistics, 2009

Ahmedin Jemal, Rebecca L. Siegel, Elizabeth Ward et al. · CA A Cancer Journal for Clinicians · 2009 · 9.7K citations · Full text

, , +16

Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial.

Howard A. Burris, Malcolm J. Moore, John Sahl Andersen et al. · Journal of Clinical Oncology · 1997 · 5.9K citations

, , +16

Low-Molecular-Weight Heparin versus a Coumarin for the Prevention of Recurrent Venous Thromboembolism in Patients with Cancer

Agnes Lee, Mark N. Levine, Ross Baker et al. · New England Journal of Medicine · 2003 · 2.5K citations · Full text

, , +17

Malignancies, Prothrombotic Mutations, and the Risk of Venous Thrombosis

Jeanet W. Blom · JAMA · 2005 · 2K citations

, , +14